Barchart.com's Chart of the Day - Stereotaxis
Related Stocks
 STXS - Stereotaxis Inc
SymLastChgPct
STXS3.65+0.20+5.80%

The Barchart Chart of the Day belongs to the medical instrument company Stereotaxis (STXS). I found the stock by using Barchart's powerful screening tool to find stocks with both the highest Weighted Alpha and highest technical buy signals, then sorted that list by the most frequent number of new highs in the last month. Next I used the Flipchart feature to review the charts for consistent price appreciation. Since the Trend Spotter signaled a buy on 11/18 the stock gained 41.35%.

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to allow physicians to navigate catheters, guidewires and stent delivery devices through the blood vessels and chambers of the heart to treatment sites.

STXS

Barchart's Opinion Trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com website when you read this report.

Barchart technical indicators:

  • 100% technical buy signals
  • 276.10+ Weighted Alpha
  • 330.84% gain in the last year
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 17 new highs and up 42.72% in the last month
  • Relative Strength Index 78.95%
  • Technical support level at 4.67
  • Recently traded at 5.28 with a 50 day moving average of 3.94

Fundamental factors:

  • Market Cap $352 million
  • Wall Street is behind the curve and not following this company and the only analysts following the stock rates it a hold
  • The individual investors have found the stock and are following the stock on Motley Fool and voted 130 to 18 that the stock will beat the market
  • 4,435 investors are also monitoring the stock on Seeking Alpha